Quigel

Quigel is a specialty biotechnology company focused on the development of high-performance hydrogel materials for medical devices and drug delivery. The company's core technology, the Quigel™ platform, consists of proprietary polymers that can be formulated to transition from a liquid to a solid gel state in response to physiological conditions. This technology is particularly well-suited for ophthalmic applications, such as sustained-release inserts for treating dry eye syndrome and glaucoma. By providing a stable, biocompatible matrix for therapeutic agents, Quigel aims to enhance the efficacy and safety of localized drug delivery. The company leverages its material science expertise to partner with pharmaceutical firms for the development of next-generation combination products.